Category
Weight Management Peptides
Metabolic support & appetite regulation
Showing 5 products
Weight Management
Retatrutide
Retatrutide (LY3437943, CAS# 2381089-83-2) is a synthetic peptide compound classified as a triple receptor agonist with binding activity at the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GcgR). Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Weight Management
Tesamorelin
Tesamorelin (TH9507, CAS# 218949-48-5) is a synthetic analogue of human growth hormone releasing hormone (hGHRH) comprising the full 44-amino-acid GHRH sequence with a trans-3-hexenoic acid group conjugated at the N-terminus. This N-terminal modification confers enhanced resistance to dipeptidyl peptidase IV (DPP-IV) enzymatic cleavage while preserving full GHRHR binding activity, making Tesamorelin a distinct pharmacological research tool compared to shorter GHRH fragments such as Sermorelin (29 AA) or Mod GRF 1-29. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Weight Management
5-Amino-1MQ
5-Amino-1MQ (5-amino-1-methylquinolin-1-ium iodide, CAS 42464-96-0) is a synthetic quinolinium small molecule and selective substrate-site inhibitor of nicotinamide N-methyltransferase (NNMT), with a reported IC₅₀ of 1.2 μM. It is studied in vitro for its effects on the NAD⁺ salvage pathway, methionine cycle flux, and metabolic enzyme activity in cell culture models. Supplied by BIOSTACKS as powder for in vitro laboratory research use.
Weight Management
Pulse (CJC + Ipamorelin)
CJC-1295 No DAC (Mod GRF(1-29), CAS# 863288-34-0) is a synthetic 29-amino acid analogue of growth hormone-releasing hormone (GHRH) with binding activity at the GHRH receptor (GHRHR). Unlike the DAC-modified variant, this form lacks the Drug Affinity Complex modification, resulting in a distinct pharmacokinetic profile relevant to short-duration signalling studies. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Weight Management
MOTS-C
MOTS-C (Mitochondrial Open reading frame of the twelve S rRNA-c, CAS# 1627580-64-6) is a 16-amino-acid mitochondria-derived peptide (MDP) encoded within the 12S rRNA gene of mitochondrial DNA — making it one of a small class of bioactive peptides with a mitochondrial rather than nuclear genomic origin. MOTS-C is studied in preclinical research for its role in mitochondria-to-nucleus retrograde signalling and its involvement in AMPK pathway activation, the folate cycle, de novo purine synthesis, and metabolic regulation models. Under cellular stress conditions, MOTS-C has been shown to translocate from mitochondria to the nucleus in vitro, where it interacts with nuclear gene regulatory elements. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.